Tagged vtak

Press Release

Catheter Precision, Inc. Announces Initial LockeT Purchase From Montefiore Medical Center

 Read More
Press Release

Catheter Precision, Inc. Announces Third Quarter Update and Financial Results

 Read More
Press Release

Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN

 Read More
Press Release

Catheter Precision, Inc. Announces Exercise of Warrants for $4.9 Million of Gross Proceeds

 Read More
Press Release

Catheter Precision to Attend Society for Cardiac Robotic Navigation With New Clinical Data Presented on October 28 – 29

 Read More
Press Release

Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO

 Read More
Press Release

Catheter Precision to Attend the International Symposium on Catheter Ablation Techniques

 Read More
Press Release

Catheter Precision Scheduled to Attend the International Ventricular Tachycardia (VT) Symposium October 11 - 12 in New York City

 Read More
Press Release

Catheter Precision Continues to Expand Clinical Data and Acceptance of VIVO

 Read More
Press Release

Catheter Precision, Inc. Receives Chinese Patent for LockeT

 Read More
Press Release

Catheter Precision, Inc. Expands LockeT Distribution to Middle East

 Read More
Press Release

Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients

 Read More
Press Release

Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory

 Read More
Press Release

Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option

 Read More
Press Release

Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering

 Read More